Advertisement
Advertisement

BDTX

BDTX logo

Black Diamond Therapeutics Inc

2.34
USD
-0.165
-6.60%
Dec 18, 15:37 UTC -5
Open

Black Diamond Therapeutics Inc Profile

About

Black Diamond Therapeutics Inc. is an oncology medicine company. It engages in discovery and development of small molecule, tumor-agnostic therapies. The company's lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor and tyrosine-protein kinase. Black Diamond Therapeutics Inc. is based in Cambridge, Massachusetts.

Info & Links

CEO

Mark A. Velleca

Headquarters

ONE MAIN STREET, 14TH FLOOR
CAMBRIDGE, MA 02142, UNITED STATES

Industry

Biotechnology

Sector

Health Technology

Website

www. blackdiamondtherapeutics.com

Auditor

PricewaterhouseCoopers LLP

Share holders

30

Employees

54

Black Diamond Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

132.11M

Enterprise Value

108.69M

Enterprise Value/EBITDA(ttm)

-1.34

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.48

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-68.08%

Return on Invested Capital(ttm)

-68.00%

Return on Assets(ttm)

-49.65%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-81.02M

Net Income Available to Common(ttm)

-73.10M

Diluted EPS(ttm)

-1.33

Share Statistics

Beta (5Y Monthly)

2.47

52-Week Change

-1.06%

S&P 500 52-Week Change

25.75%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

56.59M

Dividend Yield

0.00%

Float4

51.57M

% Held by Insiders

8.87%

% Held by Institutions

95.47%

Balance Sheet

Total Cash(mrq)

112.68M

Total Cash Per Share(mrq)

1.99

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.55%

Quick Ratio(mrq)

5.55%

Book Value Per Share(mrq)

1.72

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.84

Free Cash Flow(ytd)

-47.16M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement